Microsoft Word - DSU Degarelix FINAL sent to NICE - Eflornithine - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-06-17 10:44:39 GnRH agonists Degarelix Prostate cancer Goserelin Antiandrogen Triptorelin Buserelin Ferring Pharmaceuticals Gonadotropin-releasing hormone agonist Prostate Management of prostate cancer Androgen deprivation therapy		Microsoft Word - DSU Degarelix FINAL sent to NICE Add to Reading List Source URL: www.nicedsu.org.uk Download Document from Source Website File Size: 194,14 KB Share Document on Facebook

	Microsoft Word - DSU Degarelix FINAL sent to NICE DocID: 1oZJA - View Document
	16 SeptemberProhibited List Summary of Major Modifications and Explanatory Notes SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OFCOMPETITION) PROHIBITED SUBSTANCES DocID: 1nvS9 - View Document
	Kwartaalbericht 3e kwartaaldecember 2002 Contents DocID: 15NH9 - View Document
	State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 Williston, VTwww.dvha.vermont.gov DocID: 13avT - View Document
	Public Summary Document – November 2014 PBAC Meeting 6.7 LEUPRORELIN 30 mg injection: modified release [1 x 30 mg syringe] (&) DocID: 12zdb - View Document